NexGel Inc (NXGL)
3.32
+0.05
(+1.53%)
USD |
NASDAQ |
Nov 22, 16:00
3.34
+0.02
(+0.60%)
After-Hours: 20:00
NexGel Cash from Operations (Quarterly): -1.216M for Sept. 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | -1.216M |
June 30, 2024 | -0.70M |
March 31, 2024 | -1.092M |
December 31, 2023 | -0.587M |
September 30, 2023 | -0.723M |
June 30, 2023 | -1.217M |
March 31, 2023 | -0.709M |
December 31, 2022 | -0.649M |
September 30, 2022 | -0.848M |
June 30, 2022 | -0.698M |
March 31, 2022 | -0.797M |
December 31, 2021 | -1.197M |
Date | Value |
---|---|
September 30, 2021 | -0.523M |
June 30, 2021 | -0.688M |
March 31, 2021 | -0.345M |
December 31, 2020 | -0.423M |
September 30, 2020 | -0.398M |
June 30, 2020 | -0.32M |
March 31, 2020 | -0.66M |
December 31, 2019 | -0.387M |
September 30, 2019 | -0.268M |
June 30, 2019 | -0.603M |
March 31, 2019 | -0.556M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-1.217M
Minimum
Jun 2023
-0.32M
Maximum
Jun 2020
-0.7088M
Average
-0.693M
Median
Cash from Operations (Quarterly) Benchmarks
The Cooper Companies Inc | 207.50M |
Staar Surgical Co | 3.816M |
OrthoPediatrics Corp | -10.28M |
Innovative Eyewear Inc | -1.400M |
Perspective Therapeutics Inc | 3.366M |
Cash from Operations (Quarterly) Related Metrics
Cash from Investing (Quarterly) | -0.008M |
Cash from Financing (Quarterly) | 1.214M |
Free Cash Flow | -4.054M |
Free Cash Flow Per Share (Quarterly) | -0.1871 |
Free Cash Flow to Equity (Quarterly) | -1.551M |
Free Cash Flow to Firm (Quarterly) | -1.209M |
Free Cash Flow Yield | -19.91% |